Supplements and Children: Why Adult Products Do Not Scale Down

Children are not small adults, and treating a supplement dose as something to divide by weight is a mistake with real consequences.

Why scaling fails

Children differ in body composition, organ maturity, metabolic enzyme expression and elimination capacity, and these change through development rather than progressing linearly with weight. Immature hepatic and renal function affects clearance of many compounds. Some enzyme systems are underexpressed in infancy and overexpressed in childhood relative to adults. A weight-proportional dose can therefore be substantially too high or occasionally too low.

Where there is a genuine role

Vitamin D supplementation in infancy, which is recommended in many countries particularly for breastfed infants. Vitamin K at birth. Iron where deficiency is identified. Specific supplementation for diagnosed conditions or restricted diets under clinical guidance. In each case the recommendation comes from paediatric guidance with age-specific dosing, not from a scaled adult product.

The risks

Iron overdose is a leading cause of poisoning fatality in young children, and iron supplements should be stored inaccessibly. Fat-soluble vitamins accumulate and toxicity is a real risk. Gummy formats resemble sweets and are associated with accidental overconsumption. Botanicals have essentially no paediatric safety data. Caffeine-containing products are inappropriate. The default position for children should be food and clinical guidance rather than a supplement aisle.

How this relates to Cognizil

Cognizil works through nutrient and botanical support rather than any acute stimulant effect, so it is not designed to produce a same-day change — the Bacopa research it rests on ran to roughly twelve weeks. Our 30-day assessment guide explains how to test it properly against a recorded baseline. The Cognizil discount is applied automatically by quantity on the order page.